Press Releases

    • September 2, 2016

    Nemaura Medical Inc., sign Letter of Intent with Shenzen CAS Health Corp, for potential JV and manufacture of their sugarBEAT® system

    2nd September 2016, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura” or  the “Company”), a medical device company developing...

    Read more
    August 4, 2016

    Nemaura Medical Inc., completes second FDA Pre-submission meeting and appoints Navigant to submit IDE for Nemaura’s sugarBEAT® system

      4th August 2016, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally...

    Read more
    April 15, 2016

    Interim Clinical Data on Increased Measurement Frequency for sugarBEAT® CGM Released by Nemaura Medical

      14th April 2016, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally...

    Read more
    March 15, 2016

    Nemaura Medical Announces receipt of notification of CE Approval for its sugarBEAT® Continuous Glucose Monitoring System

    March 15th, 2016, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally invasive...

    Read more
    December 2, 2015

    Nemaura Medical Announces Joint Venture for European Launch of sugarBEAT® System

    December 2, 2015, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally invasive...

    Read more
    October 13, 2015

    Nemaura Medical Announces Filing of Application for FDA Pre-Submission Program for sugarBEAT® System

    13th October 2015, Loughborough, UK. Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing a minimally invasive...

    Read more
    October 5, 2015

    Nemaura Medical Present Positive Interim Clinical Trial Results of its sugarBEAT® System

    5th October 2015, Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing the sugarBEAT® CGM System as...

    Read more
    May 1, 2015

    Nemaura Medical to Present Positive Interim Clinical Trial Results of its sugarBEAT® System at the Marcum Microcap Conference, New York

    Nemaura Medical Inc. (OTC BB: NMRD),(“Nemaura”), a medical device company developing the sugarBEAT® CGM System as a non-invasive, wireless...

    Read more
    May 1, 2015

    Nemaura Medical to Present at the 2015 Marcum Microcap Conference

    Nemaura Medical Inc. (OTC BB: NMRD), a leading developer of minimally-invasive transdermal diagnostic technologies, announced today that Dr. D...

    Read more
    July 1, 2014

    Nemaura Medical announces licensing deal with DB Pharma (Jersey) Ltd

    Nemaura Medical announces licensing deal with DB Pharma (Jersey) Ltd., for its unique non-invasive wireless continuous glucose monitoring Watch...

    Read more